Dermatology

The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.

Latest News

FDA approval. | Image Credit: aznan - stock.adobe.com
FDA Expands Dupilumab Approval as First New Biologic for Bullous Pemphigoid

June 20th 2025

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease remission and significantly improving symptoms like itch and disease severity in adults.

Prurigo Nodularis. | Image Credit: this_baker - stock.adobe.com
Nemolizumab’s Long-Term Data Reinforce Efficacy, Tolerability in Prurigo Nodularis

June 19th 2025

Ruxolitinib cream. | Image Credit: Ladanifer - stock.adobe.com
Topical Ruxolitinib Emerges as Promising Therapy for Diverse Inflammatory Skin Conditions

June 17th 2025

Hidradenitis suppurativa. | Image Credit: Kristina Blokhin - stock.adobe.com
Pediatric Hidradenitis Suppurativa Linked to High Prevalence of Chronic Medical, Psychiatric Comorbidities

June 16th 2025

Vitiligo Awareness Month. | Image Credit: Waseem Ali Khan - stock.adobe.com
5 Things to Know for Vitiligo Awareness

June 13th 2025

Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access

Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.

Atopic Dermatitis Payer Perspectives
Continuing Medical Education
View All
June 26th 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
June 26th 2025

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology
June 26th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 26th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

patient with vitiligo covering her face with her hands | Image Credit: Savory - stock.adobe.com
June 28th 2024

Study Finds Israeli Patients With Vitiligo at Lower Risk for Parkinson Disease

Brooke McCormick
Israeli patients with vitiligo exhibit a significantly reduced risk of developing Parkinson disease (PD).
A dermatologist wearing gloves examines the skin of a sick patient. Examination and diagnosis of skin diseases-allergies, psoriasis, eczema, dermatitis | Image credit: © fusssergei - stock.adobe.com
June 26th 2024

Researchers Explore Deeper Connection Between AD, Food Allergy

AJMC Contributor
With an emerging hypothesis that inflammation of the skin prompts intestinal remodeling through various mechanisms, researchers explored the role of inflammatory signals, microbiome alterations, metabolites, and the nervous system.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 24th 2024

Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient

Iltefat Hamzavi, MD
A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 24th 2024

The Pathophysiology of Hidradenitis Suppurativa

Iltefat Hamzavi, MD
Iltefat Hamzavi, MD, describes the pathophysiology of hidradenitis suppurativa and associated comorbidities that are commonly seen in patients.
Psoriasis. Acute psoriasis on the knees, body, elbows is an autoimmune, incurable dermatological skin disease | nuzza11 - stock.adobe.com
Published: June 21st 2024 | Updated: June 21st 2024

Autoimmune Diseases Prevalent Among Patients With Psoriasis, Study Finds

Pearl Steinzor
Researchers have identified a link between psoriasis and the autoimmune diseases hypothyroidism and alopecia areata.
Pregnant woman holding stomach | Image Credit: pressmaster - stock.adobe.com
June 20th 2024

Study: Atopic Dermatitis Severely Impacts Female Patients' Sexuality, Quality of Life

Brooke McCormick
Atopic dermatitis significantly impairs female patients' sexual function, reproductive desires, and overall quality of life.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 17th 2024

Epidemiology and Impact of Hidradenitis Suppurativa

Iltefat Hamzavi, MD
An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 17th 2024

Signs and Symptoms of Hidradenitis Suppurativa (HS)

Iltefat Hamzavi, MD
Iltefat Hamzavi, MD, introduces a discussion on the treatment of hidradenitis suppurativa with an overview of the signs and symptoms of the disease.
Salt shaker spilled on table | Image Credit: Sebastian Studio - stock.adobe.com
June 11th 2024

Study Links Dietary Sodium Intake to Increased Atopic Dermatitis Prevalence, Severity

Brooke McCormick
Excessive dietary sodium intake is linked to increased prevalence and severity of atopic dermatitis (AD).
Center on Health Equity and Access
June 8th 2024

Health Equity and Access Weekly Roundup: June 8, 2024

Giuliana Grossi
This week, the Center on Health Equity and Access covered the release of the best US hospitals for equitable access, news from the CMS Health Equity conference, biomarker testing legislation, and insights on improving access for queer communities and the disparities in dermatology.
dr thomas hall
June 5th 2024

Dr Thomas Hall Explores How Geographic, Socioeconomic Factors Affect Dermatological Outcomes

Pearl Steinzor Brooke McCormick
Thomas Hall, MD, FAAD, of US Dermatology Partners, explains that disparities in dermatological care arise from the uneven distribution of dermatologists, especially in rural areas, causing delayed diagnoses and higher health care costs.
Shawn Kwatra, MD
May 30th 2024

Dr Shawn Kwatra Discusses Study Results for Nemolizumab in Prurigo Nodularis

Skylar Jeremias Pearl Steinzor
Shawn Kwatra, MD, dermatologist, John Hopkins University, recounts his study assessing the use of nemolizumab in prurigo nodularis presented at the American Academy of Dermatology conference.
AI | Image credit: sdecoret - stock.adobe.com
May 24th 2024

Harnessing AI for Improved Outcomes in Hidradenitis Suppurativa Management

Skylar Jeremias
An Italian review highlighted the potential of AI to enhance early diagnosis and treatment of hidradenitis suppurativa, though challenges such as data privacy, algorithm bias, and interpretability must be addressed to fully leverage AI's benefits in dermatology.
dermatology exam | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com
May 17th 2024

Study Reveals Decline in Inpatient Dermatology Services and Urgent Need for Strategic Support

Skylar Jeremias
A recent study found significant regional disparities and a decline in inpatient dermatology encounters and providers across the US from 2013 to 2019, highlighting the need for increased support and improved access to specialized dermatologic care.
Patient scratching atopic dermatitis (AD) on hand | Image Credit: Ольга Тернавская - stock.adobe.com
May 14th 2024

Patients With AD Prioritize Itch Control in Treatment Preferences

Brooke McCormick
A US-based discrete choice experiment survey found that patients with atopic dermatitis (AD) prioritize treatments that effectively control itching.
machine learning | Image credit: WrightStudio - stock.adobe.com
May 11th 2024

Machine Learning Model Could Predict Hidradenitis Suppurativa Diagnosis

Skylar Jeremias
A recent study applied machine learning to medical and pharmacy claims data to develop a model for predicting hidradenitis suppurativa (HS) diagnosis, highlighting the potential for improved understanding of HS underdiagnosis on a health care system level.
acne scarring | Image credit: frank29052515 - stock.adobe.com
May 4th 2024

Combining Surgical, Nonsurgical Approaches Holds Promise for Treating Facial Acne Scars

Skylar Jeremias
According to a review, recent progress offers hope in the form of treatments, such as combination therapy that utilizes surgical and nonsurgical methods, for individuals with facial acne scars.
climate change | Image credit: lamyai - stock.adobe.com
May 3rd 2024

Review Identifies Multiple Climate Change Factors Influencing Skin Cancer Rates

Skylar Jeremias
A literature review has found that ultraviolet radiation, rising temperature, and air pollution could be possible climate-related influences on skin cancer rates.
red light therapy | Image credit: Space_Cat - stock.adobe.com
April 22nd 2024

Patients With Actinic Keratosis Prefer Simulated Daylight PDT Over More Painful Red Light PDT

Skylar Jeremias
A recent study found that patients with actinic keratosis experienced more pain during red light photodynamic therapy (PDT) than simulated daylight PDT, emphasizing the need to understand patient experiences for better treatment decisions.
dr monica li
April 16th 2024

Dr Monica Li Explains Efficacy, Safety Differences Between Different Microneedling Techniques

Pearl Steinzor Brooke McCormick
Monica Li, MD, medical and cosmetic dermatologist, explained the efficacy and safety differences between radiofrequency microneedling and traditional microneedling.
syringe and vial | Image credit: PhotobyTawat - stock.adobe.com
April 11th 2024

Secukinumab Proves Successful in Treating Severe HS, Safety Persists at Week 52

Skylar Jeremias
In a recent study, secukinumab therapy demonstrated adequate safety and efficacy profiles, offering potential benefits for patients with severe hidradenitis suppurativa (HS) who found adalimumab intolerable.
dr robert sidbury
April 9th 2024

Dr Robert Sidbury on Implementing Value-Based Care Initiatives in a Pediatric Dermatology Practice

Pearl Steinzor Brooke McCormick
Robert Sidbury, MD, MPH, FAAD, division head of dermatology at Seattle Children's Hospital and professor of pediatrics at the University of Washington School of Medicine, discusses implementing value-based care initiatives in a pediatric dermatology practice.
doctor talking to patient | Image credit: Suteren Studio - stock.adobe.com
April 5th 2024

Delays in HS Diagnosis, Treatment Shed Light on Provider Education Gaps

Skylar Jeremias
Patients with hidradenitis suppurativa (HS) in Canada often wait long periods of time to receive an HS diagnosis and receive evidence-based therapy, highlighting the need for increased interdisciplinary education on HS management.
dr monica li
April 2nd 2024

Dr Monica Li Lists Microneedling Considerations, Precautions

Pearl Steinzor Brooke McCormick
Monica Li, MD, medical and cosmetic dermatologist, listed microneedling considerations and precautions so that providers can safely implement the procedure.
man's hands with atopic dermatitis | Image Credit: Ольга Тернавская - stock.adobe.com
March 20th 2024

Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD

Brooke McCormick
These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
little boy crying at school while group of students run away | Image Credit: Rido - stock.adobe.com
March 18th 2024

Patients With Vitiligo Suffer Heightened Stigma, Mental Health Risks

Brooke McCormick
Posters presented showed that patients with vitiligo have a heightened risk of stigma and subsequent mental health issues.
Patient using phone | Image Credit: guteksk7 - stock.adobe.com
March 17th 2024

AI Dermatology Mobile Apps Have Critical Efficacy, Safety Gaps, Review Says

Brooke McCormick
This scoping review discovered potential risks and critical gaps in the efficacy, safety, and transparency of current artificial intelligence (AI) dermatology mobile apps, emphasizing the need for regulatory intervention.
Shawn Kwatra, MD, dermatologist, John Hopkins University
March 15th 2024

Dr Shawn Kwatra Shares Efficacy, Safety Data of Nemolizumab in Patients With PN

Pearl Steinzor
Shawn Kwatra, MD, dermatologist, John Hopkins University, discusses late breaking study results on the long-term efficacy and safety of nemolizumab in patients with prurigo nodularis (PN).
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
March 15th 2024

Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients With Plaque Psoriasis

Pearl Steinzor
Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh, shares 16-week safety and efficacy data from the FRONTIER 2 clinical trial on JNJ-2113 for patients with moderate to severe plaque psoriasis.
Martin Dahl, PhD, senior vice president, AnaptysBio
March 11th 2024

Dr Martin Dahl Discusses the Pathophysiology of AD and Benefits of ANB032

Pearl Steinzor
AnaptysBio's senior vice president of research, Martin Dahl, PhD, discusses therapeutic strategies and pathophysiological approaches to treating patients with atopic dermatitis (AD).
<12345678
...
11>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo